Serum contents of E-selectin,sICAM-1, sVCAM-1 in patients with acute coronary syndrome

AIM:To explore the serum levels of certain adhesion molecules and its significance in acute coronary syndrome(ACS). METHODS:The subjects included 40 patients with acute myocardial infarction(AMI) and 40 patients with unstable angina pectoris (UAP). Among the 80 patients, 60 patients accepted a follow-up 4 months. At the same time we selected 40 controls from people who attended a routine health check in the university. Serum levels of E-selectin, sICAM-1, sVCAM-1 were measured by ELISA.RESULTS:Serum levels of E-selectin, sICAM-1, sVCAM-1 were significantly higher in the ACS group(AMI or UAP) than in the control group. Four months later, the levels of E-selectin, sICAM-1 became significantly lower in the follow-up group than in the ACS group, while sVCAM-1 showed no significant difference. CONCLUSION:Serum levels of E-selectin, sICAM-1 may have certain diagnostic value for ACS, and can be a useful marker reflecting the stability of the disease.     

Marked hyperphosphatasemia associated with an acute leukemia in a Great Dane

This is the report of a 5‐year‐old male neutered Great Dane with an extreme leukocytosis (544.9 × 10⁹ cells/L; RI 5.2–13.9 × 10⁹ cells/L) characterized by highly atypical round cells. Cellular morphologic features such as cytoplasmic membrane blebs, a high nuclear‐to‐cytoplasmic ratio, and nuclear indentations and irregularities and large nucleoli, as well as immunocytochemistry for CD3 and CD79, myeloperoxidase cytochemistry, and clonality testing were not conclusive for myeloid or lymphoid origin. Marked alkaline hyperphosphatasemia was present at the first visit (2783.0 U/L; RI 6–80.0 U/L), followed by a 5‐fold increase (14,000 U/L) a week later, identified as being mostly contributed by the bone‐ALP isoform (11,062 U/L; RI 0–30 U/L). In addition, the atypical leukocytes were strongly positive for cytoplasmic ALP activity. In vitro lysis of a heparin blood sample resulted in a 1.7‐fold increase of ALP activity, supporting the origin of the hyperphosphatasemia at least in part from the leukemic cell population. To the authors’ knowledge, this is a unique case of alkaline hyperphosphatasemia, due at least to a leukemic cell population producing a bone‐ALP isoform, regardless of the exact nature of the leukemia.     

Serum C-reactive protein concentration as an indicator of remission status in dogs with multicentric lymphoma

BACKGROUND: The acute-phase protein C-reactive protein (CRP) is used as a diagnostic and prognostic marker in humans with various neoplasias, including non-Hodgkin's lymphoma. OBJECTIVE: To evaluate if CRP could be used to detect different remission states in dogs with lymphoma. ANIMALS: Twenty-two dogs with untreated multicentric lymphoma. METHODS: Prospective observational study. Blood samples were collected at the time of diagnosis, before each chemotherapy session, and at follow-up visits, resulting in 287 serum samples. RESULTS: Before therapy, a statistically significant majority of the dogs (P = .0019) had CRP concentrations above the reference range (68%, 15/22). After achieving complete remission 90% (18/20) of the dogs had CRP concentrations within the reference range, and the difference in values before and after treatment was statistically significant (P < .001). CRP concentrations of dogs in complete remission (median, 1.91; range, 0.2-103) were significantly different (P = .031) from those of dogs with partial remission (median, 2.48; range, 0-89), stable disease (median, 1.77; range, 1.03-42.65), or progressive disease (median, 8.7; range, 0-82.5). There was profound variation of CRP measurements within each dog. CONCLUSIONS: CRP is useful in determining complete remission status after treatment with cytotoxic drugs. However, the individual variation between dogs means CRP concentration is not sufficiently different in other remission states to permit its use in monitoring progression of the disease. Greater reliability in determining remission status might be achieved by combining CRP concentration with other serum markers.     

新饲料添加剂N，O-羧甲基壳聚糖的急性毒性研究

【目的】研究N,O-羧甲基壳聚糖对鸡的急性毒性,评价该药的安全性;【方法】以最大浓度的N,O-羧甲基壳聚糖(10.5%),按20ml/(kg·bw)(2.1g/(kg·bw)/次)剂量24h内给鸡灌服;【结果】给药后连续观察7天,各组试验鸡全部存活,临床、剖检均未见到异常变化,测不出LD50,根据新药审批办法中关于急性毒性的要求,进行最大耐受量的测定。鸡灌服给予N,O-羧甲基壳聚糖的最大耐受量为10.5g/(kg·bw),相当于临床拟用量的3500倍;【结论】N,O-羧甲基壳聚糖毒副作用很小,临床可以安全应用。     

水环境中Ni~(2+)对鲤鱼鳃和肝脏的组织损伤

为研究水环境中Ni~(2+)对鲤鱼鳃和肝脏的组织损伤,将鲤鱼(Cyprinuscarpio)暴露在Ni~(2+)浓度为0、0.55、0.62、0.72、0.83、0.96、1.09、1.25mmol/L的水环境中进行急性毒性试验,并通过组织切片观察鳃和肝脏的组织病理变化。结果显示,Ni~(2+)对鲤鱼的96h半数致死浓度(LC_(50))为0.72 mmol/L,安全浓度(SC)为0.007 2 mmol/L。高浓度Ni~(2+)(1.25 mmol/L)试验组鲤鱼的鳃小片呼吸上皮细胞坏死、脱落,肝血窦淤血,肝细胞核固缩;中低浓度Ni~(2+)(0.72～1.09mmol/L)试验组鲤鱼的鳃小片呼吸上皮水肿浮离、细胞增生,血窦充血,肝细胞胞浆空泡化。表明水环境中的Ni~(2+)浓度高于0.007 2mmol/L时会对鲤鱼的鳃和肝脏造成急性毒性,导致鳃和肝脏出现明显的组织病理变化。     

镉对海湾扇贝的急性毒性研究

利用水生生物毒性试验方法,分5个浓度进行镉对日照海域海湾扇贝的急性毒性实验,以期对日照海域海湾扇贝养殖提供理论依据。利用概率单位和浓度对数作线性回归,得出镉对海湾扇贝(Argopectenirradiams)在24、48、96h的半致死量LC50,其值分别为5.85、4.52和3.45mg/L。并计算出镉对海湾扇贝的安全质量浓度为0.0345mg/L。实验证明,Cd对海湾扇贝是剧毒性的毒物,海湾扇贝发育越往后期,它对Cd的耐受性就越大。     

急性氨氮胁迫及毒后恢复对团头鲂幼鱼鳃、肝和肾组织结构的影响

为进一步了解氨氮对团头鲂幼鱼的毒性毒理影响,以体质量为(14.27±0.01)g的团头鲂幼鱼为研究对象,研究了氨氮胁迫对其鳃、肝、肾组织结构的影响。实验首先进行96h的氨氮胁迫,得出96h LC50,在此基础上,设置对照组(0.472 mg/L)和实验组(25 mg/L)两个氨氮浓度处理组,进行0、6、12、24、48h的氨氮胁迫,取样后剩余团头鲂幼鱼移入曝气自来水进行96h的毒后恢复实验。结果表明：96h LC50为56.492 mg/L;三种组织观察表明,氨氮胁迫6h,鳃丝毛细血管扩张,上皮组织增生;肝细胞肿胀,细胞核肿大,肝细胞空泡化;肾小球萎缩,肾小囊腔膨大,肾小管管腔缩小;胁迫12h,泌氯细胞增生,呼吸上皮细胞出现部分脱落;肝细胞水样变性、血窦扩张、细胞轮廓模糊,形成点状病灶;肾小管上皮细胞肿大、水样变性、浊肿;胁迫24h,鳃小片融合、变短,呼吸上皮细胞大面积脱落;肝细胞水样变性、血窦扩张严重,形成局部病灶;肾组织淋巴细胞浸润严重,充血,肾小球坏死,肾小管坏死;胁迫48h,鳃小片卷曲,上皮细胞部分脱落;肝细胞部分溶解、血窦扩张,形成点状病灶;肾小管上皮细胞坏死,肾小球坏死;96h恢复后,泌氯细胞和上皮组织增生严重;肝组织大面积细胞核肿大,血窦扩张;肾组织淋巴细胞浸润严重,肾小管坏死,肾小球坏死。实验表明,不同的器官之间病症的损伤程度是不同的,肝组织的损伤最严重,然后依次是鳃和肾。随着胁迫时间延长,鳃、肝和肾组织受到的损害增加,同时鱼体也产生防御反应,但96h的恢复期不足以让团头鲂幼鱼在胁迫中完全恢复,而恢复能力最差的是肾组织。     

氨氮和亚硝酸氮对南美白对虾的毒性研究

用通常的生物毒性试验方法进行了氨氮和亚硝氨氮对体长5cm南美白对虾的急性毒性试验。在海水pH8.15、水温T＝27℃、盐度S＝20．0‰条件下，求得了两种物质对南美白对虾24h、48h、72h、96h的半死浓度，提出总氨氮和非离子氨氮对南美白对虾的安全浓度分别为2．667mg/L和0．201mg/L，亚硝酸氮的安全浓度为5．551mg/L。氨氮对南美白对虾的毒性强于亚硝酸氮，并提出降低氨氮和亚硝酸氮含量的措施。